Characteristics of Apixaban-Treated Patients, Evaluation of the Dose Prescribed, and the Persistence of Treatment: A Cohort Study in Catalonia.

Ainhoa Gomez-LumbrerasJordi CortesMaria Giner-SorianoM Angeles Quijada-ManuittRosa Morros

Published in: Journal of cardiovascular pharmacology and therapeutics (2018)

The prescribed dose of apixaban did not fully follow the recommended dose, particularly in patients who were treatment naive. Patients with a prior history of anticoagulant treatment were more likely to remain persistent to treatment with apixaban.

Keyphrases

atrial fibrillation
ejection fraction

hiv infected

prognostic factors

patient reported outcomes